Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.

Ansari, Huzaifa Ul Haq; Qazi, Shurjeel Uddin; Sajid, Faiza; Altaf, Zahabia; Ghazanfar, Shamas; Naveed, Naveen; Ashfaq, Amna Shakil; Siddiqui, Abdul Hannan; Iqbal, Hamza; Qazi, Sana

Ansari, Huzaifa Ul Haq; Qazi, Shurjeel Uddin; Sajid, Faiza; Altaf, Zahabia; Ghazanfar, Shamas; Naveed, Naveen; Ashfaq, Amna Shakil; Siddiqui, Abdul Hannan; Iqbal, Hamza; Qazi, Sana.

Afiliación

Ansari HUH; Department of Internal Medicine, Dow University of Health Sciences, Pakistan. Electronic address: huzaifi1947123@gmail.com.
Qazi SU; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Sajid F; Department of Medicine, Liaquat National Hospital and Medical College, Pakistan.
Altaf Z; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Ghazanfar S; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Naveed N; Department of Medicine, Jinnah Sindh Medical University, Pakistan.
Ashfaq AS; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Siddiqui AH; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Iqbal H; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.
Qazi S; Department of Internal Medicine, Dow University of Health Sciences, Pakistan.

Endocr Pract ; 30(2): 160-171, 2024 Feb.

Article en En | MEDLINE | ID: mdl-38029929

Asunto(s)

Enfermedades Cardiovasculares; Diabetes Mellitus Tipo 2; Humanos; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/complicaciones; Hipoglucemiantes/efectos adversos; Agonistas Receptor de Péptidos Similares al Glucagón; Péptido 1 Similar al Glucagón/efectos adversos; Obesidad/tratamiento farmacológico; Obesidad/complicaciones; Enfermedades Cardiovasculares/epidemiología; Enfermedades Cardiovasculares/prevención & control; Pérdida de Peso; Lípidos; Triglicéridos; Lipoproteínas HDL; Lipoproteínas LDL; Colesterol; Receptor del Péptido 1 Similar al Glucagón/agonistas

Palabras clave

GIPRA; GLP-1 RAs; liraglutide; nondiabetic; obesity; semaglutide; tirzepatide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Endocr Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google